Atnaujinkite slapukų nuostatas

El. knyga: Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary

  • Formatas: 118 pages
  • Išleidimo metai: 04-Apr-2012
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309222174
Kitos knygos pagal šią temą:
  • Formatas: 118 pages
  • Išleidimo metai: 04-Apr-2012
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309222174
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.

Table of Contents



Front Matter 1 Introduction 2 The Importance of Innovative Regulatory Science 3 Defining a Discipline of Regulatory Science and Core Competencies for Its Workforce 4 Education and Training of a Regulatory Science Workforce 5 Career Paths Within Academia and Industry 6 International Applications of Regulatory Science 7 Collaborative Models and New Paradigms for Supporting Regulatory Science Research and Practice References Appendix A: Workshop Agenda Appendix B: Participant Biographies
Acronyms xv
1 Introduction
1(4)
Scope of the Workshop and Organization of the Summary
3(2)
2 The Importance of Innovative Regulatory Science
5(14)
Perspective from the Food and Drug Administration
6(5)
Perspective from the National Institutes of Health
11(2)
Perspective from the Pharmaceutical Industry
13(2)
Perspective from Academia
15(1)
Patient Perspective
16(1)
Principles and Themes
17(2)
3 Defining a Discipline of Regulatory Science and Core Competencies for Its Workforce
19(12)
Defining Regulatory Science Through the Lens of Translational Science
20(2)
Defining Regulatory Science as Science of Evaluation of Regulations
22(2)
Case Studies: Regulatory Science in Practice
24(1)
Core Competencies of Regulatory Science
24(4)
Defining Regulatory Science
28(3)
4 Education and Training of a Regulatory Science Workforce
31(12)
An Overview of Existing Training Programs
32(2)
Developing Education and Training Programs in Regulatory Science
34(2)
Models for Education and Training
36(1)
Fellowships and Exchange Programs
37(6)
5 Career Paths within Academia and Industry
43(8)
Career Paths in Academia
44(3)
Career Paths in Industry
47(4)
6 International Applications of Regulatory Science
51(6)
Maintaining a Robust Global Therapeutics Pipeline
52(2)
Therapeutics Development for Global Neglected Diseases
54(3)
7 Collaborative Models and New Paradigms for Supporting Regulatory Science Research and Practice
57(8)
Creating a Collaborative Environment in an Academic Setting
58(3)
A Collaborative Model for Research, Training, and Business Development
61(1)
Regulatory Science: Solving for a Larger Context
61(2)
Closing Panel
63(2)
REFERENCES
65(2)
APPENDIXES
A Workshop Agenda
67(14)
B Participant Biographies
81